Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 684.88M P/E - EPS this Y 53.50% Ern Qtrly Grth -
Income -58.68M Forward P/E -5.21 EPS next Y -8.50% 50D Avg Chg -1.00%
Sales 32.02M PEG -0.03 EPS past 5Y - 200D Avg Chg -21.00%
Dividend N/A Price/Book 3.68 EPS next 5Y 74.40% 52W High Chg -49.00%
Recommedations 3.00 Quick Ratio 7.11 Shares Outstanding 71.34M 52W Low Chg 68.00%
Insider Own 2.64% ROA -25.96% Shares Float 55.21M Beta 0.22
Inst Own 77.67% ROE -37.43% Shares Shorted/Prior 1.71M/1.80M Price 9.69
Gross Margin -173.29% Profit Margin -183.29% Avg. Volume 602,043 Target Price 1.55
Oper. Margin -457.48% Earnings Date Nov 4 Volume 227,498 Change -1.22%
About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Aclaris Therapeutics, Inc. News
11/21/24 Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
11/20/24 Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
11/19/24 Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
11/19/24 Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
11/19/24 Aclaris Therapeutics secures global rights to Biosion’s antibodies
11/19/24 ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
11/18/24 Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
11/18/24 Aclaris Therapeutics Announces $80 Million Private Placement
11/18/24 Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
11/12/24 News Flash: Analysts Just Made A Meaningful Upgrade To Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Forecasts
11/09/24 Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
11/06/24 Aclaris Therapeutics (ACRS) Reports Q3 Loss, Misses Revenue Estimates
11/06/24 Aclaris: Q3 Earnings Snapshot
11/06/24 Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
07:04 PM Discovering Penny Stocks On US Exchanges: 3 Picks Under $100M Market Cap
10/09/24 Millennium Management LLC Reduces Stake in Aclaris Therapeutics Inc
10/08/24 Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
09/18/24 Aclaris doses first subject in Phase IIa atopic dermatitis treatment trial
09/17/24 Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
09/10/24 Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
ACRS Chatroom

User Image Pajohnamo Posted - 11 hours ago

$ACRS Extremely bullish here. Market cap is so low. Lot of running room.

User Image crett Posted - 12 hours ago

$ACRS im in lets go long

User Image elnb Posted - 14 hours ago

$ACRS easy 15

User Image johntwit88 Posted - 14 hours ago

$HOTH $ACRS $XCUR $AKTX

User Image babakbb Posted - 15 hours ago

$HOTH $ACRS $XCUR $AKTX Keep holding

User Image MB0000 Posted - 1 day ago

$ACRS $12

User Image NVDAMillionaire Posted - 1 day ago

$ACRS Aclaris Therapeutics (ACRS): Pioneering Innovative Therapies for Immuno-Inflammatory Diseases https://beyondspx.com/article/aclaris-therapeutics-acrs-pioneering-innovative-therapies-for-immuno-inflammatory-diseases

User Image Game_Day Posted - 1 day ago

NOV 21 NEW PLAYS 🪬 Options $BIDU ⭐️ 10% NEW calls extended targets $MDT ⭐️ 20% reach yesterday calls VIP SIGNATURE $CMCSA 🔥 VIP alert currently 35% Stocks $PET ⭐️ 10% NEW alert JTAI ⭐️ NEW alert HOLD $ACRS ⭐️ 20%+ reach yesterday alert

User Image thetfont Posted - 1 day ago

$ACRS WeBull only platform that dropped to 4.29 at close before jumping to 4.36

User Image daflyonenatl Posted - 1 day ago

$ACRS New CNBC Article. See 100% Return Coming Jefferies says buy this pharmaceutical play, sees more than 100% upside from here

User Image teksviler Posted - 1 day ago

$STXS I don't when, but I have patience. Just like $FTK $ACRS $GEV IONQ QUBT ETN VST APLD CRM

User Image killaxor Posted - 1 day ago

$ACRS higher lows this is a healthy stock no pumpers here

User Image inspector_gadget86 Posted - 1 day ago

$ACRS money to be maid around here

User Image CarolaT Posted - 1 day ago

$ACRS director is buying 666,666 shares.

User Image G101SPM Posted - 1 day ago

$ACRS $4.10 bid. DAC (dollar average cost) $1.48 (7.17.24). CHANGE EXIT TO $10.00 FROM $7.00.

User Image GSP Posted - 1 day ago

$LUMN $SNOW $ACRS

User Image WarrenPsnik Posted - 2 days ago

$ACRS Summary of recent analyst actions …

User Image GSP Posted - 2 days ago

The last 3 stocks in my video for November 21st: $LUMN $ACRS $SNOW Watch the video here: https://greatstockpix.com/november-21st-day-trading-watch-list/ .

User Image Game_Day Posted - 2 days ago

NOV 20 NEW PLAYS 🔮 the usual all WINS Stocks $DBGI ⭐️ 7% NEW alert $ACRS ⭐️ 7% NEW alert $PRFX ⭐️ 8% yesterday ah alert to 3rd target Options $MDT ⭐️ 7% NEW calls great potential

User Image Pajohnamo Posted - 2 days ago

$ACRS looking like another leg up here soon. $7-$12. $DRUG $IBRX $TNXP

User Image Blossom_Tradez Posted - 2 days ago

$ACRS Starter initiated at 3.70 400 shares start. Will add at levels to the bear side.

User Image DonCorleone77 Posted - 2 days ago

$ACRS Guess this didn't help the stock today: Aclaris upgraded at Cantor after deal adds two 'potential blockbusters' Cantor Fitzgerald analyst Louise Chen upgraded Aclaris Therapeutics to Overweight from Neutral with no price target after the company earlier this week announced the in-licensing of two biologics from privately-held Biosion and a concurrent equity raise. Aclaris and Biosion's biologics have competitive advantages to Tezpire and Dupixent, which are "both blockbuster drugs," the analyst tells investors. Following the deal news, the firm says its upgrade is driven by the addition of "two potential blockbuster drugs" in BSI-045B and BSI-502.

User Image pdoz007 Posted - 2 days ago

$ACRS time to go up..

User Image Blossom_Tradez Posted - 2 days ago

$ACRS Going to open a starter soon

User Image AlwaysBullish99 Posted - 2 days ago

$ACRS 66 million in volume yesterday. You won't see that again unless there's significant news.

User Image AlwaysBullish99 Posted - 2 days ago

$ACRS

User Image WarrenPsnik Posted - 2 days ago

$ACRS Added here ... It was a buy-write, Dec 20 expiry.

User Image killaxor Posted - 2 days ago

$ACRS this bad boy isn’t close to being done. Accumulation zone.

User Image DarthGoat Posted - 2 days ago

$ACRS IIIIINNNNNNNNNNNNN

User Image inspector_gadget86 Posted - 2 days ago

$ACRS exclusive license agreement with Biosion for global rights (excluding Greater China) to two of the latter’s pipeline candidates, BSI-045B and BSI-502.. who’s still holding that has sub 2.4 averages ?

Analyst Ratings
HC Wainwright & Co. Neutral Sep 17, 24
HC Wainwright & Co. Neutral Aug 19, 24
HC Wainwright & Co. Neutral Jul 22, 24
HC Wainwright & Co. Neutral Jan 22, 24
BTIG Neutral Jan 11, 24
HC Wainwright & Co. Buy Dec 29, 23
Stifel Hold Dec 18, 23
HC Wainwright & Co. Buy Nov 14, 23
Cantor Fitzgerald Neutral Nov 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Oct 23 Sell 5.0767 6,000 30,460 129,724 10/25/23
Manion Douglas J. Pres and CEO Pres and CEO Mar 09 Buy 7.735 6,500 50,278 6,500 03/09/23
Walker Neal Director Director Mar 01 Sell 12.5 59,240 740,500 1,273,202 03/03/23
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Mar 01 Sell 12.5 30,837 385,462 147,724 03/03/23
Balthaser Kevin Chief Financial Offi.. Chief Financial Officer Mar 01 Sell 12.46 1,894 23,599 5,256 03/03/23
SCHIFF ANDREW N Director Director Nov 10 Sell 17.05 53,926 919,438 434,455 11/14/22
SCHIFF ANDREW N Director Director Oct 04 Sell 16.27 45,539 740,920 588,916 10/06/22
SCHIFF ANDREW N Director Director Jun 17 Sell 15.1428 19,565 296,269 06/21/22
Walker Neal President and CEO President and CEO Apr 21 Sell 15.15 70,000 1,060,500 1,245,763 04/25/22
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Apr 18 Sell 16.2766 30,000 488,298 106,386 04/20/22
Walker Neal President and CEO President and CEO Mar 11 Sell 15.9147 56,303 896,045 1,315,763 03/14/22
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Mar 10 Sell 15.5451 12,823 199,335 201,883 03/14/22
Gordon David N. Chief Medical Office.. Chief Medical Officer Jun 02 Sell 22.51 51,914 1,168,584 144,078 06/02/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer Jun 02 Sell 22.32 45,119 1,007,056 131,688 06/02/21
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Jun 02 Sell 21.91 21,790 477,419 85,342 06/02/21
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 21.91 15,037 329,461 169,872 06/02/21
Walker Neal President and CEO President and CEO Jun 02 Sell 21.9 33,260 728,394 1,232,182 06/02/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer May 07 Option 10.66 20,416 217,635 149,034 05/07/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer May 07 Sell 23.6 20,416 481,818 143,618 05/07/21
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Apr 26 Sell 26.61 87,339 2,324,091 151,720 04/26/21
Mehra Anand Director Director Feb 03 Option 18.34 14,632 268,351 30,841 02/03/21